HIRSCHMAN ORIN 13D and 13G filings for Cyclo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-02-11 6:25 pm Sale | 2021-02-09 | 13G | Cyclo Therapeutics, Inc. CYTH | HIRSCHMAN ORIN | 209,383 4.990% | -208,617 (-49.91%) | Filing |
2020-12-17 08:11 am Purchase | 2020-12-08 | 13G | Cyclo Therapeutics, Inc. CYTH | HIRSCHMAN ORIN | 418,000 9.900% | 418,000 (New Position) | Filing |